Clinical trial
A 4 Weeks, Phase II, Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 12 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Moderate to Severe Dry Eye.
NCT03982368 is registered in ClinicalTrials.gov with Dompé Farmaceutici S.p.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 4 Weeks, Phase II, Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 12 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Moderate to Severe Dry Eye.
- Lead sponsor
- Dompé Farmaceutici S.p.A
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 10, 2019
- Completion date
- July 15, 2020
- Enrollment
- 261 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye syndrome